| Literature DB >> 18582937 |
Artur Summerfield1, Kenneth C McCullough.
Abstract
Considering the pivotal roles played by dendritic cells (DCs) in both innate and adaptive immune responses, advances in the field of porcine immunology DC biology have recently progressed rapidly. As with the more extensively studied murine and human DCs, porcine DC can be generated from bone marrow haematopoietic cells or monocytes, and have been analysed in various immunological and non-immunological tissues. Both conventional DC (cDC) and plasmacytoid DC (pDC) have been characterized. The function of porcine monocyte-derived DC has not only been characterized in terms of antigen presentation and lymphocyte activation, but also their response to various ligands of pattern recognition receptors. These have been characterized in terms of the induction of DC maturation and pro-inflammatory, Th1-like or Th2-like cytokines secretion. Porcine pDC most effectively sense virus infections and are characterized by their capacity to produce large quantities of IFN-alpha and the pro-inflammatory cytokines TNF-alpha, IL-6 and IL-12. As such, the DC family as a whole is a powerful ally in the host battle against pathogen attack. Nevertheless, DC in particular tissue environments or under particular stimuli can down-regulate immune response development. This is not only important for preventing over-activation of the immune system and also for ensuring tolerance against self or "friendly" substances including food components, but may also be used as a mechanism of pathogens to evade immune responses.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18582937 PMCID: PMC7103208 DOI: 10.1016/j.dci.2008.05.005
Source DB: PubMed Journal: Dev Comp Immunol ISSN: 0145-305X Impact factor: 3.636
Comparative phenotype and tissue localisation of porcine DC subsets and related antigen presenting cells
| CD172a | CD1 | CD4 | CD11R1 | CD14 | CD16 | MHCII | CD80/86 | References | |
|---|---|---|---|---|---|---|---|---|---|
| MoDC | + | + | − | − | +/low | + | + | + | |
| GM-CSF BMDC | + | + | − | − | + | + | + | + | |
| Flt3L BMDC | + | + | − | − | +/− | + | + | + | unpublished |
| blood cDC | low | +/− | − | − | − | +/− | high | + | |
| pDC | low/− | +/− | + | − | − | +/− | + | low | |
| thyroid gland DC | + | n.d. | n.d. | n.d. | n.d. | n.d. | + | n.d. | |
| thymus DC | + | + | n.d. | n.d. | n.d. | n.d. | + | n.d. | |
| skin DC | + | + | n.d. | n.d. | ± | n.d. | + | + | |
| mucosal tissue DC | +/− | − | n.d. | +/− | − | + | + | + | |
| mucosal lymph DC | +/− | +/− | n.d. | + | n.d. | +/− | + | + | |
| monocytes | + | − | − | − | + | + | +/− | low | |
| macrophages | + | +/− | − | − | +/− | + | low | low | |
| fibrocytes | + | + | n.d. | n.d. | + | + | + | + |
Two subsets.
Variable, two subsets with some animals (see also Fig. 1).
Can be negative in mucosal tissue [55].
Not determined.
Four subsets based on CD172a/CD11RI expression and dependent on localization in LP, PP and MLN [47].
Negative on LP DC [46].
Two subsets: CD172a+CD1+CD16+ and CD172a−CD1−CD16−.
Fig. 1Phenotype of porcine blood DC. (A) Porcine CD172a+ blood APC can be differentiated into CD14+ monocytic cells and CD14− DC. Two major subpopulations of CD4− monocytic cells can be defined based on CD163 expression (depicted light blue; see also Dominguez et al., this issue). Furthermore, a small CD4+CD14+CD163+ subset with unknown function can be identified (dark blue). Porcine blood DC express relatively low levels of CD172a and lack CD14 and CD163. While cDC are CD4− (green), pDC express high levels of CD4 (red). (B) Expression of CD14, MHC class II, CD1, CD2, CD16 and CD163 on CD172ahighCD4− monocytes (light blue dots), CD172ahighCD4+ monocytic cells (dark blue dots), CD172alowCD4− cDC (green dots) and CD172alowCD4+ pDC (red dots). A representative animal is shown. Comparison of five different SPF pigs of the similar age (6–12 month old) revealed high variability in the expression levels of MHC class II, CD1, CD2 and CD16 on the DC subpopulations.
Reagents used for labelling of surface molecules on porcine APC
| CD name | Functional name | Detection | References |
|---|---|---|---|
| CD1 | mAb 76-7-4 | ||
| CD4 | mAbs 74-12-4, PT90A | ||
| CD2 | MAb MSA-2 | ||
| CD11R1 | CR3 | mAb MIL4, TMG.6-5 | |
| CD11R2 | CD11c (human) | anti-human mAb S-Hcl3 | |
| CD14 | LPS R | mAbs CAM36A, MIL2 | |
| CD16 | FcγRIII | mAb G7 | |
| CD32 | FcγRII | mAb AT-10 (anti-human) | |
| CD40 | anti-human mAb G28-5 | ||
| CD80/86 | B7-1/B7-2 | rh CTLA-4-Ig (anti-human) | |
| CD86 | B7-2 | anti-human mAb HA5.2B7 | unpublishedb |
| CD116 | GM-CSF R* | rp GM-CSF-his-tagged | |
| CD123 | IL3 R | rp IL-3-his-tagged | |
| CD163 | Scavenger R | mAb 2A10 | |
| CD172a | SIRP-α | various | |
| CD184 | CXCR4 | anti-human, clone 44708 | |
| CD191 | CCR1 | anti-human, clone 145 | |
| CD206 | mannose R | anti-human, clone 3.29B1.10 | unpublishedb |
| CD208 | DC lamp | anti-human clone 104.G4 | |
| MHC class II | various clones |
aDetected using anti-His-Tag mAb (Roche, Basel, Switzerland).
bSummerfield et al.
Fig. 2Functional specialization of porcine cDC and pDC at the interface innate-adaptive immunity. The current knowledge on PAMP responsiveness and cytokine profile is schematically represented. Porcine pDC produce not only particularly large quantities of type I IFN but also TNF-α, IL-12 and IL-6 after stimulation with certain viruses, TLR7 and TLR 9 ligands. These cytokines promote cDC maturation. The latter are involved in antigen presentation and regulate lymphocyte responses. This is partially controlled by the cytokines profile, which depends on stimulation by TLR ligands, RLR ligands, viruses and bacteria as well as other factor such as the tissue environment. The cytokine profiles can be classified as proinflammatory, Th1- and Th2-like. The influence of porcine DC on differentiation of T regulatory cells (Treg) has not yet been described.
Response of MoDC to stimulation by TLR ligands and cytokines
| MHCII | CD80/86 | endo- cytosis | T-cell activation | Cytokine secretion | References | |
|---|---|---|---|---|---|---|
| TLR/RLR ligands | ||||||
| LPS | ↑ | ↑ | ↓ | ↑ | TNF-α IL-6, IL-10 | |
| Pam-3-Cys | ↑ | ↑ | ↓ | n.d. | IL-6 | |
| LTA | ↑ | ↑ | n.d. | n.d. | IL-10 | |
| Peptidogycan | ↑ | ↑ | n.d. | n.d. | IL-12 | |
| CpG | ↑ | ↑ | n.d. | n.d. | IL-12p35 | |
| PolyIC | ↑ | ↑ | ↓ | ↑ | INF-αβIL-6, IL-12 | |
| PolyIC tf | ↑ | ↑ | n.d. | n.d. | INF-αβ | |
| mRNA tf | ↑ | ↑↑ | n.d. | ↑ | INF-αβ | |
| pDNA tf | ↑ | n.d. | n.d. | n.d. | IL-12 | |
| Other microbial components | ||||||
| CT | ↓ | ↑ | ↓ | ↓↓ | TNF-α↓, IL-10 | |
| LT | ↓ | ↑ | = | n.d. | n.d. | |
| Actinobacillus | n.d. | n.d. | n.d. | n.d. | IL-6, IL-10, IL-12 | |
| Fusarium toxin | = | ↓ | ↓ | = | IL-10↓ | |
| Cytokines, cytokine/TLR ligand cocktails | ||||||
| TNF-α | = | ↑ | n.d. | ↑↑ | n.d. | |
| TNF-α/LPS | ↑↑ | ↑↑ | ↓ | ↑ | ||
| IFN-α/pIC | ↑↑ | ↑↑ | ↓ | n.d. | n.d. | |
| IFN-α/TNF-α | ↑↑ | ↑↑ | ↓ | ↑ | n.d. | |
| IFN-α/TNF-α/TLR ligand | ↑↑↑ | ↑↑↑ | ↓ | n.d. | n.d. | |
mRNA levels analysed.
Not determined.
Transfection.
Cholera toxin.
Heat-labile enterotoxin (E. Coli).
DC interaction with viruses and IFN-α/β induction
| cDC | pDC | References | ||||
|---|---|---|---|---|---|---|
| Infection | Maturation | INF-α/β | Infection | INF-α/β | ||
| CSFV | ++ | +/- | supression | + | +++ | |
| FMDV | (+) | −/+ | + | + | ++/− | |
| Influenza V | + | + | − | + | +++ | unpublished |
| LV vector | + | + | − | + | +++ | |
| PCV2 | (+) | − | − | n.d. | supression | |
| PRRSV | + | ↓ | supression | n.d. | n.d. | |
| PRV | n.d. | n.d. | n.d. | n.d. | +++ | |
| SV | n.d. | n.d. | + | n.d. | n.d. | |
| TGEV | − | − | − | − | +++ | |
Infection with transient or abortive replication.
Unpublished results (Guzylack-Piriou and Summerfield).
Stimulation strain-dependent or FMDV complexed with immune immunoglobulins.
HIV-derived VSV-G protein pseudotyped vector.
PCV2: persisting infection.
Not determined.